Filing Flows › Pacific Biosciences of California (PACB) › Service and other revenue revenue
Pacific Biosciences of California (PACB) Service and other revenue revenue by quarter
Pacific Biosciences of California's Service and other revenue revenue was $6.6M in Q3 2026 (third quarter 2026), +8% from Q2 2026. Over the last 7 quarters it ranged from $5.6M (Q1 2026) to $6.7M (Q2 2025).
| Quarter | Service and other revenue revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $6.6M | +8% | +12% |
| Q2 2026 | $6.1M | +7% | -9% |
| Q1 2026 | $5.6M | -0.6% | -7% |
| Q4 2025 | $5.7M | -3% | — |
| Q3 2025 | $5.8M | -13% | — |
| Q2 2025 | $6.7M | +11% | — |
| Q1 2025 | $6.0M | — | — |
Q3 2026 at a glance
Pacific Biosciences of California, Q3 2026: revenue $40.6M (+6% year over year), operating margin -91.2%, net loss $37.8M, operating cash flow −$37.6M. The chart follows the revenue to costs, profit and cash.
Questions
What is Pacific Biosciences of California's Service and other revenue revenue?
Pacific Biosciences of California's Service and other revenue revenue was $6.6M in Q3 2026 (third quarter 2026), +8% from Q2 2026.
How has Pacific Biosciences of California's Service and other revenue revenue changed?
Over the last 7 quarters it ranged from $5.6M (Q1 2026) to $6.7M (Q2 2025).
Q3 2026 results → · How Pacific Biosciences of California makes money →